DrugPatentWatch Database Preview
Profile for Norway Patent: 322080
US Patent Family Members and Approved Drugs for Norway Patent: 322080
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Oct 4, 2019 | Celgene | REVLIMID | lenalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |